| ²é¿´: 403 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
Çó·Òë³ÉÖÐÎÄ
|
|||
|
To date, different mutations have been reported that result in a complete deficiency, including: two deletions (295¨C298delTCAT and 1897delC), one splice-site mutation (IVS14+IG>A), four missense mutations (85T>C, 703C>T, 2657G>A, and 2983 G>T), a deletion of two nucleotides (1039¨C1040delTG), and the point mutations P86L, S201R, S492L, D949V and H978R [13]. The 85T>C mutation might be a common polymorphism, although functional analysis of a recombinantly expressed human protein carrying the 85T>C mutation showed no significant residual mutant enzyme activity [10,14]. An in-depth discussion of the clinical import of DPD can be found in a number of review articles, and two examples are provided in Refs. [37,38], which discuss the role of DPD in cancer therapy with 5FU |
» ²ÂÄãϲ»¶
08¹¤Ñ§ 309·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
¸÷λÀÏʦºÃ£¬Çóµ÷¼Á£¬±¾¿Æ211£¬Ò»Ö¾Ô¸Ìì½ò´óѧÉúÎïÓëҽҩѧ˶£¬²îÁ½Ãû¼ȡ¡£
ÒѾÓÐ9È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ12È˻ظ´
²ÄÁÏÏà¹Ø×¨Òµ344Çóµ÷¼ÁË«·Ç¹¤¿ÆÑ§Ð£»ò¿ÎÌâ×é
ÒѾÓÐ18È˻ظ´
297Çóµ÷¼Á
ÒѾÓÐ24È˻ظ´
085600²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ19È˻ظ´
310Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Çóµ÷¼Á£¬985²ÄÁÏÓ뻯¹¤348·Ö
ÒѾÓÐ14È˻ظ´
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ42È˻ظ´
279Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¿ÆÑÐÐèÇó-Áò»¯Äøîܾ«¿óÑùÆ·
+1/399
°²»Õũҵ´óѧÀîÑǻԽÌÊÚÕÐÊÕ »¯Ñ§¡¢Å©Ò©Ñ§¡¢Ö²±£Àà2026¼¶²©Ê¿Ñо¿Éú
+3/111
½ÓÊÕ²ÄÁÏ¿ÆÑ§Ó빤³ÌºÍ»¯Ñ§×¨ÒµÑ§Ë¶µ÷¼Á-Î÷ÄϿƴó·øÉä·À»¤²ÄÁÏ
+3/80
ÉÇÍ·´óѧ˶ʿÑо¿Éúµ÷¼Á
+2/46
±±¾©Àí¹¤´óѧ£¨Ö麣£©ÕÐÊÕÈ˹¤ÖÇÄÜ·½Ïò26¼¶²©Ê¿
+1/21
ºÓ±±´óѧÑàÂó»ùÒò×éѧÓë·Ö×ÓÓýÖÖ¿ÎÌâ×éÕÐÊÕ2026¼¶¿¼Ñе÷¼ÁÉú
+1/17
Ê¡ÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÉú£¨Ò»Ö¾Ô¸07¿ªÍ·×¨Òµ£©£¬º£ÑóÉúÎïרҵÃû¶î³ä×ã
+1/15
26É격×Ô¼ö£¨ÐÂÄÜÔ´µç³Ø·½Ïò£©
+1/14
ºÓÄÏũҵ´óѧÀíѧԺ·®Á¼öοÎÌâ×éÕÐÊÕ»¯Ñ§×¨ÒµË¶Ê¿µ÷¼ÁÉú£¨¹ý¹ú¼ÒÏß¼´¿É£©
+1/10
Î人·ÄÖ¯´óѧ²ÄÁÏѧԺ½ÓÊܵ÷¼Á£¨»¹Óв¿·ÖÊ¿±ø¼Æ»®Ãû¶î£©
+1/10
ú̿¿ÆÑ§Ñо¿×ÜÔº¿óɽвÄÁÏÑо¿ÔºÔ±¹¤²©Ê¿ºóÕÐÆ¸
+1/9
ÕÔËÉ·½½ÌÊÚÁªºÏɽ´óÓÚΰӾ½ÜÇà¡¢ÑÓÊÀ´óJong-Hyun AhnԺʿÕв©Ê¿ºó ¡¢²©Ê¿Ñо¿Éú
+1/8
ÓëÆä·¢Õ¹³èÎᄐ㬲»Èç¸Ä±äÄêÇáÈ˵ĻéÁµ¹Û
+1/6
ºÓÄÏÀí¹¤´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÐÊÕ²ÄÁÏ¡¢»¯¹¤Ààרҵµ÷¼ÁÑо¿Éú
+1/4
»îÐÔ»·ÑõÏ¡ÊͼÁ
+1/4
±±»ª´óѧ¡ª¹¤Ñ§08µ÷¼ÁÈÔÓÐÓà¶î£¨³õÊÔÐ躬Êýѧ+Ó¢Ó
+1/4
ºþÄÏũҵ´óѧÄÜÔ´²ÄÁÏ´´ÐÂÍŶÓÕÐÊÕ2026»¯Ñ§×¨ÒµÑо¿Éú£¨Ñ§Ë¶£©µ÷¼Á
+1/2
³¤°²´óѧÖÇÄܱ¬ÆÆ¿ÎÌâ×éÕÐÊÕ2026¼¶²©Ê¿ºÍ˶ʿÑо¿Éú
+1/2
ÀöˮѧԺ²ÄÄÜѧԺ-ÏȽøÄÜÔ´´æ´¢ÓëÆ÷¼þ¿ÎÌâ×é-26½ìÑо¿ÉúÕÐÉú-£¨ÐÂÄÜÔ´µç³Ø·½Ïò£©
+1/1
ÖйúÃñº½´óѧÕÐÊÕ2026ÄêÎïÀíѧѧÊõ˶ʿ
+1/1
3Â¥2011-03-11 20:40:20
µØÍ¼ÎÏÅ£
Òø³æ (СÓÐÃûÆø)
- ·ÒëEPI: 9
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 339.4
- Ìû×Ó: 71
- ÔÚÏß: 16.5Сʱ
- ³æºÅ: 804596
ЦÊÀ¿ñÁú(½ð±Ò+25, ·ÒëEPI+1): ллÄã 2011-03-11 20:27:42
|
ÄúÊDz»ÊǰÑһƪDPDµÄ×ÛÊöÒ»µãµãÌùѽ¡£ ĿǰÒѱ¨µÀÓжà¸öÍ»±äµ¼ÖÂÍêÈ«¹¦ÄÜȱʧ£¬ÕâЩͻ±äÓУºÁ½¸öȱʧͻ±ä£¨295¨C298delTCAT and 1897delC£©£¬Ò»¸ö¼ô½ÓλµãÍ»±ä(IVS14+IG>A)£¬4¸ö´íÒåÍ»±ä(85T>C, 703C>T, 2657G>A, and 2983 G>T)£¬Ò»¸öÁ½¸öºËÜÕËáµÄȱʧͻ±ä(1039¨C1040delTG)ºÍ¼¸¸öµãÍ»±äP86L, S201R, S492L, D949V and H978R¡£85T>CÍ»±ä¿ÉÄÜÊÇÒ»¸ö±È½ÏÆÕ±éµÄ¶à̬ÐÔ£¬µ«Ð¯´ø85T>CÍ»±äµÄÖØ×éÈËDPDµ°°×²¢Ã»ÓÐÃ÷ÏÔµÄÍ»±äøµÄ»îÐÔ²ÐÓà¡£´óÁ¿×ÛÊöÒѾÉîÈëÌÖÂÛÁËDPDµÄÖØÒªÁÙ´²×÷Óã¬ÎÄÏ×37£¬38ÖоÍÓÐÁ½¸öÀý×Ó£¬ÕâÁ½Æª×ÛÊöÌÖÂÛÁËDPDÔÚ5FUÖÎÁư©Ö¢ÖеÄ×÷Óᣠ|
2Â¥2011-03-11 10:50:33














»Ø¸´´ËÂ¥